Kawasaki disease - a new manifestation of COVID-19 in children.
- Author:
Fu-Yong JIAO
1
Author Information
1. Center of Diagnosis and Treatment of Kawasaki Disease in Shaanxi Province/Children's Hospital, Shaanxi Provincial People's Hospital, Xi'an 710068, China. 3105089948@qq.com.
- Publication Type:Journal Article
- MeSH:
Betacoronavirus;
Child;
Coronavirus Infections;
Humans;
Mucocutaneous Lymph Node Syndrome;
Pandemics;
Pneumonia, Viral
- From:
Chinese Journal of Contemporary Pediatrics
2020;22(7):677-678
- CountryChina
- Language:Chinese
-
Abstract:
Since the outbreak of coronavirus disease 2019 (COVID-19) in Europe and America, the incidence of Kawasaki disease has significantly increased, which has aroused concern among pediatricians and parents. COVID-19 can cause inflammation reactions of multiple organs, which is similar to the systemic vasculitis of Kawasaki disease, and even COVID-19 can cause skin rash on the extremities of the limbs, which is also similar to Kawasaki disease. The cause of Kawasaki disease is currently unclear, and it cannot be ruled out that COVID-19 is associated with an increased incidence of Kawasaki disease. Therefore, during the epidemic of COVID-19, if children have symptoms similar to Kawasaki disease, intravenous immunoglobulin is recommended as early as possible to reduce the incidence of coronary artery lesions.
